PARKINANE LP 2 mg, extended-release capsule 50 capsules
Active ingredients: Trihexyphenidyl hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule50 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PARKINANE LP 2 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 50 gélule(s)
- Marketing authorisation holder
- CNX THERAPEUTICS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 1975
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68401010CIP73174717CIP133400931747178Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIHEXYPHÉNIDYLE (CHLORHYDRATE DE)gélule | 2 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.